Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014 (2014), Article ID 872725, 7 pages
http://dx.doi.org/10.1155/2014/872725
Review Article

Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institution of Digestive Disease, Shanghai Inflammatory Bowel Disease Research Center, Shanghai 200127, China

Received 31 December 2013; Accepted 17 February 2014; Published 27 March 2014

Academic Editor: Paolo Gionchetti

Copyright © 2014 Yuan Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Martinez-Medina, X. Aldeguer, F. Gonzalez-Huix, D. Acero, and L. J. Garcia-Gil, “Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis,” Inflammatory Bowel Diseases, vol. 12, no. 12, pp. 1136–1145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Jostins, S. Ripke, R. K. Weersma et al., “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” Nature, vol. 491, no. 7422, pp. 119–124, 2012. View at Publisher · View at Google Scholar
  3. B. Chassaing and A. Darfeuille-Michaud, “The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases,” Gastroenterology, vol. 140, no. 6, pp. 1720–1728, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. W. Walker, J. D. Sanderson, C. Churcher et al., “High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease,” BMC Microbiology, vol. 11, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Arumugan, J. Raes, E. Pelletier et al., “Enterotypes of the human gut microbioma,” Nature, vol. 473, no. 7346, pp. 174–180, 2011. View at Publisher · View at Google Scholar
  6. P. Louis and H. J. Flint, “Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine,” FEMS Microbiology Letters, vol. 294, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. D. Packey and R. B. Sartor, “Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases,” Current Opinion in Infectious Diseases, vol. 22, no. 3, pp. 292–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Machiels, M. Joossens, J. Sabino et al., “A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis,” Gut, 2013. View at Publisher · View at Google Scholar
  9. Y. Dörffel, A. Swidsinski, V. Loening-Baucke, B. Wiedenmann, and M. Pavel, “Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy,” Inflammatory Bowel Diseases, vol. 18, no. 9, pp. 1663–1671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Machiels, M. Joossens, V. de Preter et al., “Association of Faecalibacterium prausnitzii and disease activity in ulcerative colitis,” Gastroenterology, vol. 140, supplement 1, article S142, no. 5, 2011. View at Publisher · View at Google Scholar
  11. J. Luther, M. Dave, P. D. R. Higgins, and J. Y. Kao, “Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature,” Inflammatory Bowel Diseases, vol. 16, no. 6, pp. 1077–1084, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Varela, C. Manichanh, M. Gallart et al., “Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis,” Alimentary Pharmacology & Therapeutics, vol. 38, no. 2, pp. 151–161, 2013. View at Publisher · View at Google Scholar
  13. A. Swidsinski, V. Loening-Baucke, M. Vaneechoutte, and Y. Doerffel, “Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora,” Inflammatory Bowel Diseases, vol. 14, no. 2, pp. 147–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Vermeiren, P. van den Abbeele, D. Laukens et al., “Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment,” FEMS Microbiology Ecology, vol. 79, no. 3, pp. 685–696, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Joossens, G. Huys, M. Cnockaert et al., “Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives,” Gut, vol. 60, no. 5, pp. 631–637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Wang, L. Chen, R. Zhou et al., “Increased proportion of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease,” Journal of Clinical Microbiology, 2013. View at Publisher · View at Google Scholar
  17. W. Jia, R. N. Whitehead, L. Griffiths et al., “Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?” FEMS Microbiology Letters, vol. 310, no. 2, pp. 138–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Sokol, P. Seksik, J. P. Furet et al., “Low counts of Faecalibacterium prausnitzii in colitis microbiota,” Inflammatory Bowel Diseases, vol. 15, no. 8, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Andoh, H. Kuzuoka, T. Tsujikawa et al., “Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease,” Journal of Gastroenterology, vol. 47, no. 12, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar
  20. B. Willing, J. Halfvarson, J. Dicksved et al., “Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease,” Inflammatory Bowel Diseases, vol. 15, no. 5, pp. 653–660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Fujimoto, H. Imaeda, K. Takahashi et al., “Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn’s disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 4, pp. 613–619, 2013. View at Publisher · View at Google Scholar
  22. M. Galecka, P. Szachta, A. Bartnicka, L. Łykowska-Szuber, P. Eder, and A. Schwiertz, “Faecalibacterium prausnitzii and Crohn’s disease—is there any connection?” Polish Journal of Microbiology, vol. 62, no. 1, pp. 91–95, 2013. View at Google Scholar
  23. S. Miquel, R. Marín, O. Rossi et al., “Faecalibacterium prausnitzii and human intestinal health,” Current Opinion in Microbiology, vol. 16, no. 3, pp. 255–261, 2013. View at Publisher · View at Google Scholar
  24. R. Hansen, R. K. Russell, C. Reiff et al., “Microbiota of Pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis,” The American Journal of Gastroenterology, vol. 107, no. 12, pp. 1913–1922, 2012. View at Publisher · View at Google Scholar
  25. C. L. O'Brien, G. E. Allison, and P. Pavli, “The more the merrier: Faecalibacterium prausnitzii in Crohn’s disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 5, pp. 757–759, 2013. View at Publisher · View at Google Scholar
  26. H. Sokol, B. Pigneur, L. Watterlot et al., “Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 43, pp. 16731–16736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Qiu, M. Zhang, X. Yang, N. Hong, and C. Yu, “Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis,” Journal of Crohn's and Colitis, vol. 7, no. 11, pp. e558–e568, 2013. View at Publisher · View at Google Scholar
  28. M. Wang, G. Molin, S. Ahrné, D. Adawi, and B. Jeppsson, “High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes,” Digestive Diseases and Sciences, vol. 52, no. 3, pp. 620–627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Mondot, S. Kang, J. P. Furet et al., “Highlighting new phylogenetic specificities of Crohn's disease microbiota,” Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 185–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. H. Siaw and A. Hart, “Commentary: is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis?” Alimentary Pharmacology & Therapeutics, vol. 38, no. 5, p. 551, 2013. View at Publisher · View at Google Scholar
  31. S. Maccaferri, B. Vitali, A. Klinder et al., “Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 12, pp. 2556–2565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Benjamin, C. R. Hedin, A. Koutsoumpas et al., “Smokers with active Crohn’s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota,” Inflammatory Bowel Diseases, vol. 18, no. 6, pp. 1092–1100, 2012. View at Publisher · View at Google Scholar
  33. S. Angelberger, W. Reinisch, A. Makristathis et al., “Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation,” The American Journal of Gastroenterology, vol. 108, no. 10, pp. 1620–1630, 2013. View at Publisher · View at Google Scholar
  34. S. D. McLaughlin, A. W. Walker, C. Churcher et al., “The bacteriology of pouchitis: a molecular phylogenetic analysis using 16s rRNA gene cloning and sequencing,” Annals of Surgery, vol. 252, no. 1, pp. 90–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Cucchiara, V. Iebba, M. P. Conte, and S. Schippa, “The microbiota in inflammatory bowel disease in different age groups,” Digestive Diseases, vol. 27, no. 3, pp. 252–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. K. E. Ashelford, N. A. Chuzhanova, J. C. Fry, A. J. Jones, and A. J. Weightman, “At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies,” Applied and Environmental Microbiology, vol. 71, no. 12, pp. 7724–7736, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. H. Duncan, P. Louis, and H. J. Flint, “Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product,” Applied and Environmental Microbiology, vol. 70, no. 10, pp. 5810–5817, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. G. T. Macfarlane and S. Macfarlane, “Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics,” Journal of Clinical Gastroenterology, vol. 45, supplemment, pp. S120–S127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Himmel, Y. Yao, P. C. Orban, T. S. Steiner, and M. K. Levings, “Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers,” Immunology, vol. 136, no. 2, pp. 115–122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. F. J. Benus, T. S. van der Werf, G. W. Welling et al., “Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects,” British Journal of Nutrition, vol. 104, no. 5, pp. 693–700, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Prideaux, S. Kang, J. Wagner et al., “Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 19, no. 13, pp. 2906–2918, 2013. View at Publisher · View at Google Scholar